Ataur Rahman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ataur Rahman has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Hasanuzzaman Manik
Department of Genetic Engineering and Biotechnology, University of Rajshahi, Motihar, Rajshahi 6205, Bangladesh
1 shared publication - Jamiatul Husna Shathi
Department of Biochemistry and Biotechnology, Khwaja Yunus Ali University, Chouhali, Sirajganj 6751, Bangladesh
1 shared publication - Kazi Md. Faisal Hoque
Molecular Biology and Protein Science Laboratory, Department of Genetic Engineering & Biotechnology, University of Rajshahi, Rajshahi-6205, Bangladesh
1 shared publication - Mohammad Shahangir Biswas
Department of Biochemistry and Biotechnology University of Science & Technology Chittagong (USTC) Chittagong Bangladesh
1 shared publication - Rubait Hasan
Department of Biochemistry and Biotechnology, Khwaja Yunus Ali University, Chouhali, Sirajganj 6751, Bangladesh
1 shared publication - Tariqul Islam
Department of Biochemistry and Biotechnology, School of Biomedical Sciences, Khwaja Yunus Ali University, Sirajganj, Bangladesh
1 shared publication
Latest Publications
- Open Access
- 1 January 2025
- Published by Wiley in Journal of Toxicology
- Vol. 2025 (1) , 5464388
Biochemical and Biological Profiles of Bangladeshi Russell’s Viper Snake Venom and Neutralizing Efficacy by Indian VINS Polyvalent Antivenom
The Russell’s viper ( Daboia russelii ) has recently become a significant threat to human life in Bangladesh. Given its wide distribution across South Asia, the venom characteristics and lethality can vary by region with different toxicological properties. Hence, we investigated the characteristics of Bangladeshi Russell’s viper venom (BRVV) through SDS–PAGE profiling, reverse‐phase HPLC analysis, along with assessments of phospholipase A 2 (PLA 2 ), edema‐inducing, hemolytic, hemorrhagic, and coagulant activities, histopathology, and blood biochemistry, following established protocols. We also studied the neutralization efficacy of polyvalent antivenom from VINS Bio Products Ltd., India (VPAV) against BRVV. RP‐HPLC analysis of BRVV displayed 15 peaks, and SDS–PAGE showed high‐intensity protein bands within the 15–70 kDa range. The median lethal dose (LD 50 ) for mice was found to be 0.33 mg/kg intraperitoneally (i.p.), and venom exposure resulted in neurotoxic symptoms such as limb paralysis, respiratory difficulties, and sluggishness. BRVV exhibited strong PLA 2 , procoagulant, hemorrhagic, indirect hemolytic, and edema‐inducing activities but poor direct hemolytic activity. Venom administration also significantly increased levels of alanine aminotransferase (ALT), alkaline phosphatase (ALP), aspartate aminotransferase (AST), cholesterol, total protein, uric acid, blood urea nitrogen (BUN), and creatinine in mouse serum, indicating organ damage. Histopathological examination revealed cell vacuolization, congestion, hemorrhage, inflammatory infiltrations, and necrosis in venom‐exposed tissues, validating the abnormal serum biochemistry. The neutralization study revealed that VPAV had limited efficacy against BRVV, suggesting the presence of venom proteins not fully neutralized by the antivenom. Altogether, these findings suggest that the Russell’s viper is a medically significant venomous snake in Bangladesh, and VPAV is only partially effective in reducing the venom’s toxic effects. Therefore, region‐specific venoms must be considered in antivenom development for more effective treatment in envenomation cases.
- 1 January 2025
- Published by Wiley in Journal of Toxicology
- Vol. 2025 (1) , 5464388
Open AccessBiochemical and Biological Profiles of Bangladeshi Russell’s Viper Snake Venom and Neutralizing Efficacy by Indian VINS Polyvalent Antivenom
The Russell’s viper ( Daboia russelii ) has recently become a significant threat to human life in Bangladesh. Given its wide distribution across South Asia, the venom characteristics and lethality can vary by region with different toxicological properties. Hence, we investigated the characteristics of Bangladeshi Russell’s viper venom (BRVV) through SDS–PAGE profiling, reverse‐phase HPLC analysis, along with assessments of phospholipase A 2 (PLA 2 ), edema‐inducing, hemolytic, hemorrhagic, and coagulant activities, histopathology, and blood biochemistry, following established protocols. We also studied the neutralization efficacy of polyvalent antivenom from VINS Bio Products Ltd., India (VPAV) against BRVV. RP‐HPLC analysis of BRVV displayed 15 peaks, and SDS–PAGE showed high‐intensity protein bands within the 15–70 kDa range. The median lethal dose (LD 50 ) for mice was found to be 0.33 mg/kg intraperitoneally (i.p.), and venom exposure resulted in neurotoxic symptoms such as limb paralysis, respiratory difficulties, and sluggishness. BRVV exhibited strong PLA 2 , procoagulant, hemorrhagic, indirect hemolytic, and edema‐inducing activities but poor direct hemolytic activity. Venom administration also significantly increased levels of alanine aminotransferase (ALT), alkaline phosphatase (ALP), aspartate aminotransferase (AST), cholesterol, total protein, uric acid, blood urea nitrogen (BUN), and creatinine in mouse serum, indicating organ damage. Histopathological examination revealed cell vacuolization, congestion, hemorrhage, inflammatory infiltrations, and necrosis in venom‐exposed tissues, validating the abnormal serum biochemistry. The neutralization study revealed that VPAV had limited efficacy against BRVV, suggesting the presence of venom proteins not fully neutralized by the antivenom. Altogether, these findings suggest that the Russell’s viper is a medically significant venomous snake in Bangladesh, and VPAV is only partially effective in reducing the venom’s toxic effects. Therefore, region‐specific venoms must be considered in antivenom development for more effective treatment in envenomation cases.